Unaudited Financial Results For Quarter Ended June 30, 2018
Unaudited financial results for quarter ended June 30, 201813-08-2018
13-08-2018
Board Meeting Intimation for Board Meeting On August 13, 2018
SHALBY LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2018 ,inter alias, to consider and approve We hereby inform you that a meeting of Board of Directors of Shalby Limited is scheduled to be held Monday, August 13, 2018, inter alia to approve and take on record the unaudited standalone financial results of the Company for quarter ended June 30, 2018....06-08-2018
Shareholding for the Period Ended June 30, 2018
Shalby Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here20-07-2018
Revised Audited Financial Results For Quarter And Year Ended March 31, 2018
With reference to captioned subject, we submit herewith revised audited standalone and consolidated financial results for quarter and year ended March 31, 2018 with minor changes resolving the discrepancies raised by National Stock Exchange of lndia Limited. The said rectification has been carried out for some inadvertent technical error as well as regrouping of some of the items as we have implemented Ind AS first time in the Company. Please...20-07-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Conference call with Nine Rivers Capital13-07-2018
Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 011110 Name of the Signatory :- Jayesh PatelDesignation :- Company Secretary and Compliance Officer11-07-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Shalby Hospitals announces a Centre for Liver Disease & Transplantation (CLDT) in Ahmedabad with two successful liver transplant - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ('the SEBI LODR')06-07-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investor/Analyst meeting pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201506-07-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investor/Analyst meeting pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201502-07-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investor/Analyst meeting pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201526-06-2018